Up 75% in 5 years, I reckon this FTSE 250 still has lots to give!

Our writer explains why this FTSE 250 stock could still continue to provide growth and returns despite already being on a good run of late.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One FTSE 250 stock I reckon looks like an exciting opportunity is Spire Healthcare (LSE: SPI).

Here’s why I’d be willing to buy some shares when I next have some investable cash.

Private healthcare

Spire is a private healthcare firm with 40 private hospitals and eight clinics. The business caters to those individuals with private medical insurance, as well as others willing to pay as a one-off to have private medical care. Interestingly, it also helps the NHS with some services as the ailing state-backed provider continues to struggle with backlogs.

Spire shares have been rising in recent years. Over a 12-month period they’re up 11% from 215p at this time last year, to current levels of 239p. Going back even further, an impressive rise of 75% from 136p to current levels is hard to ignore.

My investment case

The current state of the NHS is where my belief that further growth is on the cards. Waiting lists are only rising, and many are turning to the private sector for help — those who can, at least.

Furthermore, with resources stretched, the NHS is already turning to providers like Spire to lend a hand. As the population is growing, and ageing, this reliance could also grow. Both aspects could help boost Spire’s performance and returns.

There are two issues that worry me for Spire. One is that of the debt levels on its balance sheet. They’re probably a bit higher than I’d like, and this is a worry. Sometimes paying down debt can take precedence over returns, and can hurt investor sentiment too.

The other issue I have is an overhaul of the NHS could mean the government could end outsourcing operations to private firms. At present, Spire’s NHS revenues are growing nicely and contributing to the firm’s growth. If this were to end, performance and returns could be dented.

Back to the bull case then, I can’t see the NHS radically changing overnight. Such an endeavour can take years, if not decades, especially with the current economic climate as it is. Spire’s recent results have only shown performance growth, and I’m confident this trend will continue.

Next, Spire shares offer a small dividend yield of just under 1%. I can see this level of return growing if performance continues on an upward trajectory. Although, I do understand that dividends are never guaranteed.

Finally, based on analyst forecasts, the shares look cheap on a forward price-to-earnings growth ratio of 0.8. Any reading below one can indicate a share is undervalued. However, I do understand forecasts don’t always come to fruition.

Final thoughts

I only see the NHS’ reliance on private firms, and people looking to go private for medical treatment, spiking in the years to come. This could benefit Spire, if you ask me.

Overall, solid growth prospects, an enticing valuation, and potentially growing returns help my investment case.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Forget Lloyds’ cheap share price! I’d rather consider this FTSE 100 bargain share

Lloyds' share price might appear too cheap to miss at first glance. But this FTSE-listed share could be a better…

Read more »

Market Movers

Down 6% today, is the BT share price gearing up for a larger fall?

Jon Smith points out why the BT share price has tumbled today, but flags up why the reasoning behind the…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

This FTSE 100 stock is down 25% from its 52-week high. Should I buy?

Analysts think the price-to-earnings ratio of this FTSE 100 stock could fall by half in the next two years if…

Read more »

Investing Articles

£10,000 invested in Nvidia stock just two weeks ago is already worth…

Nvidia stock's been making big losses and big gains so far in 2025, at least on paper. But long-term valuation…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Here’s why Lloyds shares have dipped sharply

Lloyds shares got a boost recently when the Treasury petitoned the Supreme Court to go easy on the car loan…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

A £10,000 investment in BAE Systems shares 5 years ago is now worth…

BAE Systems' shares have lifted off since the start of the decade. But can the FTSE 100 defence giant continue…

Read more »

Dividend Shares

£8,000 invested in high-yield dividend stocks could make this amount of passive income

Jon Smith explains how dividend shares with yields in excess of 8% can be used carefully in order to build…

Read more »

Investing Articles

£5,000 invested in Tesco shares 2 years ago is now worth…

Over the last two years, Tesco shares have provided investors with gains of around 30% per year when dividends are…

Read more »